Top Neurosurgeon Joins Ocutrx’s Scientific Advisory Board

Ocutrx Technologies, Inc. has added renowned neurosurgeon Robert Louis, M.D., to its Scientific Advisory Board.

Director of the Skull Base and Pituitary Tumor Program at Hoag Memorial Hospital Presbyterian in Newport Beach, Calif., Dr. Louis is internationally recognized for pioneering minimally invasive and endoscopic neurosurgical procedures. He has long championed the use of emerging technologies—including intraoperative augmented reality/virtual reality (AR/VR) imaging—to push the boundaries of possibilities in brain and spine surgery.

His appointment marks a strategic step for Ocutrx as it extends its flagship DigiLoupes technology beyond orthopedic and spinal applications into complex neurosurgery. Dr. Louis’s expertise will help shape DigiLoupes for delicate procedures such as brain tumor resection, treatment of spinal disorders, and management of neurological conditions like epilepsy and hydrocephalus.

“Dr. Louis is a change-maker in surgical science and a true visionary in applying technology to elevate patient care,” Ocutrx Founder/CEO/Chief Technology Officer Michael Freeman said. “His leadership will be invaluable as we develop next-generation visualization tools that deliver unprecedented clarity, precision, and efficiency for neurosurgeons.”

Dr. Louis has published extensively and lectures worldwide on advanced neurosurgical techniques, AR/VR integration, and the future of digital surgery. He is deeply committed to training the next generation of surgeons and reimagining the OR of tomorrow.

“Ocutrx’s bold vision aligns perfectly with my passion for innovation in the operating room,” Dr. Louis said. “DigiLoupes is more than an upgrade—it’s a paradigm shift for real-time visualization. Together, we have an opportunity to redefine how surgeons see, decide, and operate in some of the most delicate and high-stakes procedures.”

Anchored in the United States and Europe, Ocutrx Technologies leads in AR/XR and 3D visualization, expanding its horizons across various industries. Founded by Michael and Mitch Freeman—two Emmy Award-winning inventors of mobile video in the 1990s—the company emerged from a passion to tackle the adversities of advanced macular degeneration. Their OcuLenz headset corrects vision for patients with advanced macular degeneration for better vision and life quality. Complementing this, Ocutrx’s OR-Bot 3D Surgical Visualization Theatre sets new benchmarks in surgical methodologies, offering surgeons unmatched resolution, cinematic quality, and depth precision. While its initial focus is on the ophthalmic sector, Ocutrx envisions catering to multiple patient and surgical arenas. Strengthening its position, Ocutrx recently acquired Spectrum AMT, a U.S. Food and Drug Administration-certified manufacturing facility, further bolstering its innovation capacities.